SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Immucell Corp/DE – ‘10-K’ for 12/31/19 – ‘EXCEL’

On:  Friday, 3/27/20, at 3:22pm ET   ·   For:  12/31/19   ·   Accession #:  1213900-20-7650   ·   File #:  1-12934

Previous ‘10-K’:  ‘10-K’ on 3/22/19 for 12/31/18   ·   Next:  ‘10-K’ on 3/30/21 for 12/31/20   ·   Latest:  ‘10-K’ on 4/1/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/20  Immucell Corp/DE                  10-K       12/31/19   97:4.9M                                   Edgar Agents LLC/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    577K 
 3: EX-10.20    Severance Agreement Between the Company and         HTML     78K 
                Michael F. Brigham Dated as of March 25, 2020                    
 4: EX-10.21    Amended and Restated Incentive Compensation         HTML     32K 
                Agreement Between the Company and Bobbi Jo                       
                Brockmann Dated as of March 25, 2020                             
 2: EX-10.9     +Form of Incentive Stock Option Agreement           HTML     32K 
 5: EX-23.1     Consent of Wipfli LLP                               HTML     25K 
 6: EX-23.2     Consent of Rsm Us LLP                               HTML     25K 
 7: EX-31       Certification -- §302 - SOA'02                      HTML     28K 
 8: EX-32       Certification -- §906 - SOA'02                      HTML     26K 
68: R1          Document and Entity Information                     HTML     64K 
17: R2          Balance Sheets                                      HTML    120K 
47: R3          Balance Sheets (Parenthetical)                      HTML     37K 
82: R4          Statements of Operations                            HTML     78K 
69: R5          Statements of Comprehensive Loss                    HTML     42K 
19: R6          Statements of Stockholders' Equity                  HTML     62K 
48: R7          Statements of Stockholders' Equity (Parenthetical)  HTML     26K 
80: R8          Statements of Cash Flows                            HTML    131K 
72: R9          Business Operations                                 HTML     29K 
28: R10         Summary of Significant Accounting Policies          HTML     78K 
39: R11         Cash, Cash Equivalents and Short-Term Investments   HTML     31K 
88: R12         Trade Accounts Receivable, Net                      HTML     27K 
56: R13         Inventory                                           HTML     30K 
27: R14         Prepaid Expenses and Other Current Assets           HTML     30K 
38: R15         Property, Plant and Equipment, Net                  HTML     34K 
87: R16         Business Acquisition                                HTML     30K 
55: R17         Intangible Assets                                   HTML     38K 
29: R18         Accounts Payable and Accrued Expenses               HTML     31K 
37: R19         Bank Debt                                           HTML     59K 
86: R20         Contingent Liabilities and Commitments              HTML     36K 
74: R21         Stockholders' Equity                                HTML     70K 
24: R22         Revenue                                             HTML     35K 
54: R23         Gain on Sale of Assets                              HTML     27K 
85: R24         Other Expenses, Net                                 HTML     30K 
73: R25         Income Taxes                                        HTML     52K 
23: R26         Segment Information                                 HTML     29K 
53: R27         Related Party Transactions                          HTML     28K 
83: R28         Employee Benefits                                   HTML     29K 
75: R29         Subsequent Events                                   HTML     29K 
58: R30         Summary of Significant Accounting Policies          HTML    128K 
                (Policies)                                                       
89: R31         Summary of Significant Accounting Policies          HTML     48K 
                (Tables)                                                         
35: R32         Cash, Cash Equivalents and Short-Term Investments   HTML     29K 
                (Tables)                                                         
25: R33         Inventory (Tables)                                  HTML     31K 
59: R34         Prepaid Expenses and Other Current Assets (Tables)  HTML     31K 
90: R35         Property, Plant and Equipment, Net (Tables)         HTML     33K 
36: R36         Intangible Assets (Tables)                          HTML     42K 
26: R37         Accounts Payable and Accrued Expenses (Tables)      HTML     30K 
57: R38         Bank Debt (Tables)                                  HTML     58K 
91: R39         Stockholders' Equity (Tables)                       HTML     54K 
66: R40         Revenue (Tables)                                    HTML     36K 
76: R41         Other Expenses, Net (Tables)                        HTML     29K 
51: R42         Income Taxes (Tables)                               HTML     52K 
20: R43         Summary of Significant Accounting Policies          HTML     49K 
                (Details)                                                        
67: R44         Summary of Significant Accounting Policies          HTML     32K 
                (Details 1)                                                      
77: R45         Summary of Significant Accounting Policies          HTML     33K 
                (Details 2)                                                      
52: R46         Summary of Significant Accounting Policies          HTML     49K 
                (Details Textual)                                                
21: R47         Cash, Cash Equivalents and Short-Term Investments   HTML     36K 
                (Details)                                                        
65: R48         Cash, Cash Equivalents and Short-Term Investments   HTML     28K 
                (Details Textual)                                                
78: R49         Trade Accounts Receivable, Net (Details)            HTML     27K 
94: R50         Inventory (Details)                                 HTML     34K 
61: R51         Prepaid Expenses and Other Current Assets           HTML     36K 
                (Details)                                                        
34: R52         Prepaid Expenses and Other Current Assets (Details  HTML     28K 
                Textual)                                                         
45: R53         Property, Plant and Equipment, Net (Details)        HTML     56K 
93: R54         Property, Plant and Equipment, Net (Details         HTML     29K 
                Textual)                                                         
60: R55         Business Acquisition (Details)                      HTML     47K 
33: R56         Intangible Assets (Details)                         HTML     41K 
44: R57         Intangible Assets (Details 1)                       HTML     41K 
92: R58         Intangible Assets (Details Textual)                 HTML     32K 
62: R59         Accounts Payable and Accrued Expenses (Details)     HTML     41K 
16: R60         Bank Debt (Details)                                 HTML     30K 
50: R61         Bank Debt (Details 1)                               HTML     42K 
81: R62         Bank Debt (Details 2)                               HTML     72K 
71: R63         Bank Debt (Details Textual)                         HTML     99K 
15: R64         Contingent Liabilities and Commitments (Details)    HTML     59K 
49: R65         Stockholders' Equity (Details)                      HTML     79K 
79: R66         Stockholders' Equity (Details 1)                    HTML     50K 
70: R67         Stockholders' Equity (Details 2)                    HTML     32K 
18: R68         Stockholders' Equity (Details Textual)              HTML    185K 
46: R69         Revenue (Details)                                   HTML     29K 
41: R70         Revenue (Details 1)                                 HTML     31K 
31: R71         Gain on Sale of Assets (Details)                    HTML     34K 
63: R72         Other Expenses, Net (Details)                       HTML     30K 
96: R73         Income Taxes (Details)                              HTML     53K 
42: R74         Income Taxes (Details 1)                            HTML     70K 
32: R75         Income Taxes (Details 2)                            HTML     54K 
64: R76         Income Taxes (Details Textual)                      HTML     54K 
97: R77         Segment Information (Details)                       HTML     36K 
43: R78         Related Party Transactions (Details)                HTML     34K 
30: R79         Employee Benefits (Details)                         HTML     32K 
40: R80         Subsequent Events (Details)                         HTML     34K 
22: XML         IDEA XML File -- Filing Summary                      XML    172K 
95: EXCEL       IDEA Workbook of Financial Reports                  XLSX     94K 
 9: EX-101.INS  XBRL Instance -- iccc-20191231                       XML   1.27M 
11: EX-101.CAL  XBRL Calculations -- iccc-20191231_cal               XML    191K 
12: EX-101.DEF  XBRL Definitions -- iccc-20191231_def                XML    446K 
13: EX-101.LAB  XBRL Labels -- iccc-20191231_lab                     XML   1.13M 
14: EX-101.PRE  XBRL Presentations -- iccc-20191231_pre              XML    838K 
10: EX-101.SCH  XBRL Schema -- iccc-20191231                         XSD    193K 
84: ZIP         XBRL Zipped Folder -- 0001213900-20-007650-xbrl      Zip    145K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/24  Immucell Corp./DE                 10-K       12/31/23   98:8.7M                                   EdgarAgents LLC/FA
 3/29/23  Immucell Corp./DE                 10-K       12/31/22   98:7M                                     EdgarAgents LLC/FA
 3/30/22  Immucell Corp./DE                 10-K       12/31/21  100:6.5M                                   EdgarAgents LLC/FA
 3/30/21  Immucell Corp./DE                 10-K       12/31/20   94:4.9M                                   EdgarAgents LLC/FA
Top
Filing Submission 0001213900-20-007650   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 7:37:13.1am ET